Marksans Pharma strengthens European presence with €7.5 million QliniQ acquisition - CNBC TV18
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Obsidian Therapeutics has acquired Galera Therapeutics, a healthcare services other business in Pennsylvania. Galera Therapeutics is a healthcare services other company, and Obsidian Therapeutics acquisitions focus on expanding healthcare M&A capabilities in PA acquisitions. The strategic acquisition supports merger acquisition plans to broaden service offerings and strengthen the combined healthcare platform. The announced merger acquisition is structured as a strategic acquisition, with deal size undisclosed and closing subject to customary conditions and approvals.
Filed under
Powered by Tentt
Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Marksans Pharma→QliniQ
Jun 1, 2026
Frazier Healthcare Partners→Altruix
May 31, 2026
Signos
May 31, 2026
Sterling Bay→Pacific Center
May 29, 2026